Elevance Health Inc. (ELV) Q4 2025 (USD): Adj. EPS 3.33 (exp. 3.10), Revenue 49.3bln (exp. 49.82bln), guides FY26 adj. EPS 25.5 (exp. 27.01)

Elevance Health's adjusted EPS beat expectations, indicating stronger profitability than anticipated.

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Otis Worldwide Corporation (OTIS) Q4 2025 (USD): EPS 1.03 (exp. 1.04), Revenue 3.80bln (exp. 3.90bln)

Scotts Miracle-Gro (SMG) reportedly makes a deal to sell its cannabis-supply unit, via WSJ

Elevance Health Inc. (ELV) Q4 2025 (USD): Adj. EPS 3.33 (exp. 3.10), Revenue 49.3bln (exp. 49.82bln), guides FY26 adj. EPS 25.5 (exp. 27.01)

Newsquawk Daily US Opening News - 28th January 2026

ASML (ASML NA) executive says recent announcements by AI/chip names will have a positive impact on the Co., references SK Hynix (000660 KS) and Micron (MU), among others

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

However, the revenue miss and lower guidance for FY26 suggests potential challenges ahead, which could lead to a cautious market reaction as it reflects concerns about growth sustainability in a competitive landscape.

Related headlines

The whole workspace, free to try.

Try it free